Biogen Inc.
BIIB
$210.73
-$1.77-0.83%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -84.64% | 32.85% | -118.34% | 20.08% | 8.77% |
| Total Depreciation and Amortization | 21.51% | 11.57% | 8.80% | 10.61% | 22.28% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 191.10% | 47.55% | 66.48% | 229.20% | 68.85% |
| Change in Net Operating Assets | 69.85% | 61.65% | -484.10% | -25.49% | -318.66% |
| Cash from Operations | 178.99% | 148.94% | -32.72% | 36.01% | -74.29% |
| Capital Expenditure | -53.76% | -38.01% | -11.70% | -32.00% | 20.60% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 4,267.11% | -1,451.96% | -5,838.16% | 115.57% | -106.08% |
| Cash from Investing | -6,635.44% | -342.92% | -6,522.04% | 97.03% | -112.22% |
| Total Debt Issued | 38.46% | -- | -- | -- | -- |
| Total Debt Repaid | 37.33% | -- | -- | -- | -600.00% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -248.98% | -90.43% | 1,710.13% | -1,868.18% | 2.08% |
| Cash from Financing | 11,176.92% | -90.43% | -1,834.18% | -1,872.73% | 95.23% |
| Foreign Exchange rate Adjustments | -104.98% | -152.48% | 103.36% | -107.55% | 642.06% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1,406.98% | 67.58% | -226.41% | 626.47% | -80.77% |